Shares in Hims Hers Health Inc (NYSE:HIMS) fell Friday after Citigroup (NYSE:C) analysts downgraded the stock to Sell/High Risk, citing overvaluation concerns tied to its GLP-1 revenue stream.

The former TOWIE star, 43, took to her Instagram to announce the 'secret' behind her smaller figure, as she revealed she had ...

Gemma left some of her 2.2 million social media followers in awe when she mentioned she had partnered with Yazen, a company ...

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst expectations.

Obesity levels in the UK may have peaked and could start dropping ‘significantly’ in 2025 due to weight loss jabs, according ...

We believe a recession is coming,’ says Jean-François Tardif, president and portfolio manager at Timelo Investment Management ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Sharon Mann has lost nearly 30 pounds since starting on Mounjaro, a GLP-1 medication. Dr. Sanjay Gupta reports.

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...